Clinical Trial Update: Umbilical Cord Blood Mononuclear Cell Transplant to Treat Chronic Spinal Cord Injury [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial evaluating umbilical cord blood mononuclear cell transplant for chronic spinal cord injury has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Spinal Cord Injury

Drugs mentioned

• Umbilical cord blood mononuclear cell transplant

Snippet

Sponsor: China Spinal Cord Injury Network | Conditions: Spinal Cord Injuries | Phase 1, Phase 2 | Status: COMPLETED